NAGE FY 2020 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+28.0% YoY

Gross Profit

$35M59.5% margin

Operating Income

-$20M-33.5% margin

Net Income

-$20M-33.6% margin

EPS (Diluted)

$-0.33

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$38M

Total Liabilities

$22M

Stockholders' Equity

$16M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$46M	+28.0%
Gross Profit	$35M	$26M	+36.9%
Operating Income	-$20M	-$31M	+36.6%
Net Income	-$20M	-$32M	+38.0%